CAPRICOR THERAPEUTICS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Capricor Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Capricor Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -113 %, a 81.7% increase year-over-year.
  • Capricor Therapeutics, Inc. annual Return On Equity for 2023 was -300 %, a 82.2% decline from 2022.
  • Capricor Therapeutics, Inc. annual Return On Equity for 2022 was -164 %, a 183% decline from 2021.
  • Capricor Therapeutics, Inc. annual Return On Equity for 2021 was -58.1 %, a 6.2% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -113 +505 +81.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -220 +103 +31.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -232 -9.45 -4.25% Jan 1, 2024 Mar 31, 2024
Q4 2023 -300 -135 -82.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -618 -496 -407% Jul 1, 2023 Sep 30, 2023
Q2 2023 -323 -234 -260% Apr 1, 2023 Jun 30, 2023
Q1 2023 -222 -150 -209% Jan 1, 2023 Mar 31, 2023
Q4 2022 -164 -106 -183% Oct 1, 2022 Dec 31, 2022
Q3 2022 -122 -68.5 -128% Jul 1, 2022 Sep 30, 2022
Q2 2022 -89.9 -33.8 -60.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -72 -19.1 -36.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -58.1 -3.39 -6.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -53.5 +2.31 +4.14% Jul 1, 2021 Sep 30, 2021
Q2 2021 -56.1 +10.9 +16.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -52.8 +76.1 +59% Jan 1, 2021 Mar 31, 2021
Q4 2020 -54.7 +130 +70.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -55.8 +208 +78.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -66.9 +203 +75.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -129 +96 +42.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -185 +6.22 +3.25% Oct 1, 2019 Dec 31, 2019
Q3 2019 -264 -268 -6873% Jul 1, 2019 Sep 30, 2019
Q2 2019 -270 -297 -1133% Apr 1, 2019 Jun 30, 2019
Q1 2019 -225 -314 -353% Jan 1, 2019 Mar 31, 2019
Q4 2018 -191 -48.8 -34.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 3.9 -257 -98.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 26.2 -357 -93.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 89 -359 -80.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -143 -883 -119% Oct 1, 2017 Dec 31, 2017
Q3 2017 261 -721 -73.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 383 -764 -66.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 448 +1.7K Jan 1, 2017 Mar 31, 2017
Q4 2016 741 +1.14K Oct 1, 2016 Dec 31, 2016
Q3 2016 982 +1.59K Jul 1, 2016 Sep 30, 2016
Q2 2016 1.15K +4.62K Apr 1, 2016 Jun 30, 2016
Q1 2016 -1.25K -1.77K -339% Jan 1, 2016 Mar 31, 2016
Q4 2015 -403 -563 -350% Oct 1, 2015 Dec 31, 2015
Q3 2015 -606 -958 -272% Jul 1, 2015 Sep 30, 2015
Q2 2015 -3.48K -3.98K -792% Apr 1, 2015 Jun 30, 2015
Q1 2015 524 -172 -24.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 161 -733 -82% Oct 1, 2014 Dec 31, 2014
Q3 2014 353 +1.72K Jul 1, 2014 Sep 30, 2014
Q2 2014 502 +1.03K Apr 1, 2014 Jun 30, 2014
Q1 2014 696 +921 Jan 1, 2014 Mar 31, 2014
Q4 2013 894 +1.04K Oct 1, 2013 Dec 31, 2013
Q3 2013 -1.37K -1.43K -2311% Jul 1, 2013 Sep 30, 2013
Q2 2013 -524 -507 -3078% Apr 1, 2013 Jun 30, 2013
Q1 2013 -225 -187 -485% Jan 1, 2013 Mar 31, 2013
Q4 2012 -145 Oct 1, 2012 Dec 31, 2012
Q3 2012 61.9 Jul 1, 2012 Sep 30, 2012
Q2 2012 -16.5 Apr 1, 2012 Jun 30, 2012
Q1 2012 -38.6 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.